| # | Title | Journal | Year | Citations |
|---|
| 1 | Heart failure: preventing disease and death worldwide | ESC Heart Failure | 2014 | 921 |
| 2 | Heart failure after myocardial infarction: incidence and predictors | ESC Heart Failure | 2021 | 243 |
| 3 | Improving care for patients with acute heart failure: before, during and after hospitalization | ESC Heart Failure | 2014 | 222 |
| 4 | Heart failure is associated with depletion of core intestinal microbiota | ESC Heart Failure | 2017 | 202 |
| 5 | Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies | ESC Heart Failure | 2020 | 180 |
| 6 | Muscle wasting and sarcopenia in heart failure and beyond: update 2017 | ESC Heart Failure | 2017 | 168 |
| 7 | Exercise and heart failure: an update | ESC Heart Failure | 2018 | 136 |
| 8 | Empagliflozin reduces Ca/calmodulin‐dependent kinase II activity in isolated ventricular cardiomyocytes | ESC Heart Failure | 2018 | 131 |
| 9 | Transthyretin cardiac amyloidosis: an update on diagnosis and treatment | ESC Heart Failure | 2019 | 113 |
| 10 | Highlights in heart failure | ESC Heart Failure | 2019 | 109 |
| 11 | Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID‐19): autopsy reveals a ferroptosis signature | ESC Heart Failure | 2020 | 93 |
| 12 | Skeletal muscle wasting in chronic heart failure | ESC Heart Failure | 2018 | 91 |
| 13 | Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure | ESC Heart Failure | 2016 | 90 |
| 14 | Heart failure in Southeast Asia: facts and numbers | ESC Heart Failure | 2015 | 89 |
| 15 | Features of atrial fibrillation in wild‐type transthyretin cardiac amyloidosis: a systematic review and clinical experience | ESC Heart Failure | 2018 | 89 |
| 16 | Machine learning‐based prediction of heart failure readmission or death: implications of choosing the right model and the right metrics | ESC Heart Failure | 2019 | 89 |
| 17 | Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction | ESC Heart Failure | 2018 | 88 |
| 18 | Heart failure epidemiology and novel treatments in Japan: facts and numbers | ESC Heart Failure | 2016 | 82 |
| 19 | Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives | ESC Heart Failure | 2021 | 82 |
| 20 | Machine learning vs. conventional statistical models for predicting heart failure readmission and mortality | ESC Heart Failure | 2021 | 82 |
| 21 | Cardiac muscle wasting in individuals with cancer cachexia | ESC Heart Failure | 2017 | 80 |
| 22 | Left bundle branch area pacing delivery of cardiac resynchronization therapy and comparison with biventricular pacing | ESC Heart Failure | 2020 | 79 |
| 23 | Echocardiographic abnormalities and predictors of mortality in hospitalized COVID‐19 patients: the ECHOVID‐19 study | ESC Heart Failure | 2020 | 77 |
| 24 | Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis | ESC Heart Failure | 2020 | 76 |
| 25 | Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID‐19 pandemic | ESC Heart Failure | 2021 | 74 |
| 26 | Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta‐analysis | ESC Heart Failure | 2019 | 73 |
| 27 | Clinical characteristics of hospitalized heart failure patients with preserved, mid‐range, and reduced ejection fractions in Japan | ESC Heart Failure | 2019 | 73 |
| 28 | Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock | ESC Heart Failure | 2021 | 69 |
| 29 | Geriatric nutritional risk index predicts all‐cause deaths in heart failure with preserved ejection fraction | ESC Heart Failure | 2019 | 68 |
| 30 | Palliative care in heart failure: facts and numbers | ESC Heart Failure | 2017 | 67 |
| 31 | Empagliflozin inhibits Na+/H+ exchanger activity in human atrial cardiomyocytes | ESC Heart Failure | 2020 | 67 |
| 32 | Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides | ESC Heart Failure | 2018 | 65 |
| 33 | Sarcopenia in heart failure: a systematic review and meta‐analysis | ESC Heart Failure | 2021 | 65 |
| 34 | The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions | ESC Heart Failure | 2019 | 64 |
| 35 | Comparison of feature tracking, fast‐SENC, and myocardial tagging for global and segmental left ventricular strain | ESC Heart Failure | 2020 | 64 |
| 36 | Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus | ESC Heart Failure | 2020 | 64 |
| 37 | Focused echocardiography and lung ultrasound protocol for guiding treatment in acute heart failure | ESC Heart Failure | 2018 | 63 |
| 38 | Anaemia, iron deficiency and heart failure in 2020: facts and numbers | ESC Heart Failure | 2020 | 63 |
| 39 | Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study | ESC Heart Failure | 2015 | 62 |
| 40 | Obesity paradox in heart failure: a heavy matter | ESC Heart Failure | 2016 | 58 |
| 41 | Assessing health‐related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach | ESC Heart Failure | 2019 | 58 |
| 42 | Native myocardial T1 time can predict development of subsequent anthracycline‐induced cardiomyopathy | ESC Heart Failure | 2018 | 57 |
| 43 | Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK | ESC Heart Failure | 2019 | 57 |
| 44 | Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) | ESC Heart Failure | 2017 | 56 |
| 45 | Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization | ESC Heart Failure | 2017 | 56 |
| 46 | Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis | ESC Heart Failure | 2018 | 56 |
| 47 | Low fibre intake is associated with gut microbiota alterations in chronic heart failure | ESC Heart Failure | 2020 | 56 |
| 48 | Cardiomyocyte‐derived exosomal microRNA‐92a mediates post‐ischemic myofibroblast activation both in vitro and ex vivo | ESC Heart Failure | 2020 | 55 |
| 49 | Pulmonary artery catheter use in acute myocardial infarction‐cardiogenic shock | ESC Heart Failure | 2020 | 54 |
| 50 | Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure | ESC Heart Failure | 2016 | 53 |
